Literature DB >> 16034073

Cutting edge: HLA-E binds a peptide derived from the ATP-binding cassette transporter multidrug resistance-associated protein 7 and inhibits NK cell-mediated lysis.

Stacey L Wooden1, Suzanne R Kalb, Robert J Cotter, Mark J Soloski.   

Abstract

HLA-E is an MHC class Ib molecule that binds nonamer peptides derived from the leader sequence of MHC class 1a molecules and is the major ligand for CD94/NKG2 receptors found on NK and T cells. Using the MHC class Ia-null cell line 721.221, we find that surface HLA-E increases following heat shock at 42 degrees C and NK cell-mediated lysis is inhibited using heat-stressed 721.221 targets. We have used mass spectrometry to identify and sequence a novel peptide from HLA-E following heat shock, ALALVRMLI, derived from the transmembrane domain of the human ATP-binding cassette protein, multidrug resistance-associated protein, MRP7. Pulsing 721.221 targets with synthetic MRP7 peptide results in strong inhibition of NK cell-mediated lysis that is reversible using anti-CD94 and anti-class I mAbs. This report is the first to identify a non-MHC leader inhibitory peptide bound to HLA-E and provides insight into the immunoregulatory role of HLA-E during cell stress.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16034073     DOI: 10.4049/jimmunol.175.3.1383

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

Review 1.  Regulation of self-tolerance by Qa-1-restricted CD8(+) regulatory T cells.

Authors:  Hye-Jung Kim; Harvey Cantor
Journal:  Semin Immunol       Date:  2011-12       Impact factor: 11.130

Review 2.  Stranger in a strange land.

Authors:  Joan S Hunt
Journal:  Immunol Rev       Date:  2006-10       Impact factor: 12.988

Review 3.  The CD94/NKG2 family of receptors: from molecules and cells to clinical relevance.

Authors:  Francisco Borrego; Madhan Masilamani; Alina I Marusina; Xiaobin Tang; John E Coligan
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

Review 4.  ABCC10, ABCC11, and ABCC12.

Authors:  Gary D Kruh; Yanping Guo; Elizabeth Hopper-Borge; Martin G Belinsky; Zhe-Sheng Chen
Journal:  Pflugers Arch       Date:  2006-07-26       Impact factor: 3.657

Review 5.  The emerging role of HLA-E-restricted CD8+ T lymphocytes in the adaptive immune response to pathogens and tumors.

Authors:  Gabriella Pietra; Chiara Romagnani; Claudia Manzini; Lorenzo Moretta; Maria Cristina Mingari
Journal:  J Biomed Biotechnol       Date:  2010-06-22

6.  Variation in the ligand binding domains of the CD94/NKG2 family of receptors in the squirrel monkey.

Authors:  Michelle L LaBonte; Joanne Russo; Stephanie Freitas; Dawn Keighley
Journal:  Immunogenetics       Date:  2007-09-25       Impact factor: 2.846

Review 7.  Multidrug resistance associated proteins in multidrug resistance.

Authors:  Kamlesh Sodani; Atish Patel; Rishil J Kathawala; Zhe-Sheng Chen
Journal:  Chin J Cancer       Date:  2011-11-18

8.  The switch from latent to productive infection in epstein-barr virus-infected B cells is associated with sensitization to NK cell killing.

Authors:  Isabel Y Pappworth; Eddie C Wang; Martin Rowe
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

9.  CD94-NKG2A recognition of human leukocyte antigen (HLA)-E bound to an HLA class I leader sequence.

Authors:  Emma J Petrie; Craig S Clements; Jie Lin; Lucy C Sullivan; Darryl Johnson; Trevor Huyton; Annie Heroux; Hilary L Hoare; Travis Beddoe; Hugh H Reid; Matthew C J Wilce; Andrew G Brooks; Jamie Rossjohn
Journal:  J Exp Med       Date:  2008-03-10       Impact factor: 14.307

10.  HLA-E: Presentation of a Broader Peptide Repertoire Impacts the Cellular Immune Response-Implications on HSCT Outcome.

Authors:  Thomas Kraemer; Alexander A Celik; Trevor Huyton; Heike Kunze-Schumacher; Rainer Blasczyk; Christina Bade-Döding
Journal:  Stem Cells Int       Date:  2015-08-12       Impact factor: 5.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.